Market open Closes in 3 hr 41 min
Prices delayed by at least 15 minutes | Prices updated on 13 May 2025, 07.55 BST | Print
Rua Life Sciences PLC (RUA)
ORD 5PThis share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPPand can be used with Dividend reinvestment
Company profile
RUA Life Sciences PLC is a biomedical polymer technology, components, and medical device company. The company's principal activities comprise exploiting the value of its IP and know-how, medical device contract manufacturing, and development of cardiovascular devices. Its business segments are Royalty and License Income (Biomaterials), Contract Manufacture, Product Development (Vascular), and Product Innovation (Structural Heart). It derives the majority of its revenue from the Contract Manufacture segment. Geographically, it derives the majority of its revenue from the USA and has a presence in Switzerland, Italy, the UK, and Israel.
Address
c/o Kergan Stewart LLP
163 Bath Street
Glasgow
GBR
G2 4SQ
Major shareholders
Name | Amount | Holding (%) |
---|---|---|
Dowgate Capital Ltd | 8,017,678 | 12.92 |
Hargreaves Lansdown Asset Management | 5,597,098 | 9.02 |
Interactive Investor | 4,562,843 | 7.35 |
Rathbones Investment Management Ltd | 4,053,704 | 6.53 |
Clive & Gillian Titcomb | 4,027,272 | 6.49 |
A J Bell Securities Ltd | 3,009,493 | 4.85 |
Mark Bradshaw | 2,555,454 | 4.12 |
Charles Stanley Stockbrokers | 2,030,365 | 3.27 |
Jarvis Investment Management Ltd | 1,951,688 | 3.14 |
Key personnel
Name | Position |
---|---|
Mr. Ian Leslie Ardill | Non-Executive Director |
Mr. William Donald Brown | Executive Director,Chief Executive Officer |
Mr. John McKenna | Non-Executive Director |
Mr. John Louis Ely | Non-Executive Director |
Mr. Geoffrey Alan Berg | Non-Executive Director,Chairman |
Mr. Lachlan Arthur Smith | Executive Director,Company Secretary and Group Chief Financial Officer |
Dr. Iain Crawford Anthony | Executive Director,Director of Clinical and Regulatory Affairs |
Forecast key dates
Previous key dates
Activity analysis
Geographical analysis
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2025 AJ Bell. All rights reserved.